Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI15-225

This is an open-label, multi-center pilot study designed to evaluate the efficacy as well as the safety of combining pembrolizumab with Yttrium-90 (Y90) radioembolization in subjects with poor prognosis (high-risk) hepatocellular carcinoma who are not eligible for liver transplant or surgical resection and who have well compensated liver function.

Status: Open to Accrual

  • Condition: Hepatocellular carcinoma
  • Intervention:
    • Drug: Pembrolizumab
    • Drug: Y90 radioembolization
  • Phase: Pilot study

For full description, see www.clinicaltrials.gov. (Study #NCT03099564).

Read a news release about this trial.

Funding for this study is provided by Merck Sharp & Dohme Corp.

Project Manager: Ahran Lee, alee@hoosiercancer.org; (317) 634-5842, ext. 14.